Unraveling the potential: mRNA therapeutics in oncology
Messenger ribonucleic acid (mRNA) technology is a promising platform for cancer immunotherapy. Unlike traditional vaccines that prevent infectious diseases, mRNA’s role in oncology is to stimulate or enhance the immune response against tumor antigens. This review provides an overview of mRNA’s histo...
Saved in:
| Main Authors: | Karol Gawalski, Weronika Przybyszewska, Jaromir Hunia, Alicja Gawalska, Aleksandra Rymarz |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1643444/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
mRNA vaccines and SiRNAs targeting cancer immunotherapy: challenges and opportunities
by: Zhen Lv, et al.
Published: (2025-07-01) -
Recent progress in mRNA cancer vaccines
by: Ruhui Yao, et al.
Published: (2024-12-01) -
Novel mRNA adjuvant ImmunER enhances prostate cancer tumor-associated antigen mRNA therapy via augmenting T cell activity
by: Zhen Xu, et al.
Published: (2024-12-01) -
mRNA vaccines in the context of cancer treatment: from concept to application
by: Qiang Fu, et al.
Published: (2025-01-01) -
Development of mRNA rabies vaccines
by: Zixin Fang, et al.
Published: (2024-12-01)